Clinical Research Protocol Writing Design

Richmond Pharmacology collaborates closely with sponsors to develop protocols that address the unique needs and objectives of each trial.

Protocol design is critical, governing the precise conduct of a study. Richmond has extensive expertise in creating Clinical Study Protocols aligned with ICH guidelines. Protocols are developed with input from our Research Physicians and Principal Investigators, ensuring they meet trial requirements effectively.

Why Choose Richmond Pharmacology?

-Expert protocol design
Efficient processes
Collaborative partnership
ICH compliance
Proven track record

Get In Touch

Contact us today to discuss your project. Our team is ready to collaborate and help achieve your research goals.

Our experienced Clinical Research Scientists are dedicated to ensuring that your study design not only aligns with your specified endpoints but also achieves them through the most efficient and effective methods.

Get in touch today

Latest news

Medicines Marketing UK / EU vs US: Why Your Launch Strategy Needs a Continental Divide - Dr Lisa Campbell, Director of Regulatory Strategy

September 12, 2025
A UK CRO’s perspective on planning clinical trials for global success For pharmaceutical companies preparing for global expansion, launching in both the US and EU / UK markets often seems like the natural next step. Yet success in one region does not guarantee success in the other.
Read more

Events

JSCPT 2025

5 – 6 December 2025
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
View event